AR094658A1 - Formulación de sales de rehidratación liposomal - Google Patents

Formulación de sales de rehidratación liposomal

Info

Publication number
AR094658A1
AR094658A1 ARP140100123A ARP140100123A AR094658A1 AR 094658 A1 AR094658 A1 AR 094658A1 AR P140100123 A ARP140100123 A AR P140100123A AR P140100123 A ARP140100123 A AR P140100123A AR 094658 A1 AR094658 A1 AR 094658A1
Authority
AR
Argentina
Prior art keywords
salts
formulation
liposomal rehydration
concentration
rehydration salts
Prior art date
Application number
ARP140100123A
Other languages
English (en)
Inventor
Luis Barbarini Alejandro
Nicastro Alcides
Original Assignee
Fast Rehydration Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fast Rehydration Llc filed Critical Fast Rehydration Llc
Priority to ARP140100123A priority Critical patent/AR094658A1/es
Priority to MX2016009229A priority patent/MX2016009229A/es
Priority to BR112016016269A priority patent/BR112016016269A2/pt
Priority to AU2015207485A priority patent/AU2015207485B2/en
Priority to PCT/ES2015/070003 priority patent/WO2015107241A1/es
Priority to US15/111,485 priority patent/US20160331778A1/en
Publication of AR094658A1 publication Critical patent/AR094658A1/es
Priority to US15/723,241 priority patent/US20180021372A1/en
Priority to US15/723,228 priority patent/US10238687B2/en
Priority to US15/797,031 priority patent/US20180049983A1/en
Priority to US16/554,797 priority patent/US10751283B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/72Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
    • A23L2/74Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration using membranes, e.g. osmosis, ultrafiltration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

Una formulación de sales de rehidratación liposomal que comprende liposomas de fosfatidilcolina, antioxidante, sales, agua, y una relación de inclusión porcentual de sales (sales retenidas dentro de dichos liposomas/sales totales) de al menos 40% y un proceso para su elaboración que utiliza la ultrafiltración tangencial. Reivindicación 5: La formulación de la reivindicación 1 caracterizada porque dichas sales son seleccionadas del conjunto comprendido por cloruro de sodio en una concentración de entre 2,0 y 2,6 g/l, citrato de potasio de entre 1,8 y 2,5 g/l, citrato de sodio en una concentración de entre 2,2 y 2,9 g/l, y sus mezclas.
ARP140100123A 2014-01-14 2014-01-14 Formulación de sales de rehidratación liposomal AR094658A1 (es)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ARP140100123A AR094658A1 (es) 2014-01-14 2014-01-14 Formulación de sales de rehidratación liposomal
MX2016009229A MX2016009229A (es) 2014-01-14 2015-01-07 Formulacion de sales de rehidratacion liposomal.
BR112016016269A BR112016016269A2 (pt) 2014-01-14 2015-01-07 Formulação de sais de re-hidratação lipossomal
AU2015207485A AU2015207485B2 (en) 2014-01-14 2015-01-07 Formulation of liposome rehydration salts
PCT/ES2015/070003 WO2015107241A1 (es) 2014-01-14 2015-01-07 Formulación de sales de rehidratación liposomal
US15/111,485 US20160331778A1 (en) 2014-01-14 2015-01-07 Formulation of liposome rehydration salts
US15/723,241 US20180021372A1 (en) 2014-01-14 2017-10-03 Treatment methods for dehydration using liposomal rehydration salt formulation
US15/723,228 US10238687B2 (en) 2014-01-14 2017-10-03 Method for preparing a liposomal rehydration salt formulation
US15/797,031 US20180049983A1 (en) 2014-01-14 2017-10-30 Liposomal rehydration salt formulation and associated methods of use
US16/554,797 US10751283B2 (en) 2014-01-14 2019-08-29 Liposomal rehydration salt formulation and associated methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP140100123A AR094658A1 (es) 2014-01-14 2014-01-14 Formulación de sales de rehidratación liposomal

Publications (1)

Publication Number Publication Date
AR094658A1 true AR094658A1 (es) 2015-08-19

Family

ID=53542443

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100123A AR094658A1 (es) 2014-01-14 2014-01-14 Formulación de sales de rehidratación liposomal

Country Status (6)

Country Link
US (4) US20160331778A1 (es)
AR (1) AR094658A1 (es)
AU (1) AU2015207485B2 (es)
BR (1) BR112016016269A2 (es)
MX (1) MX2016009229A (es)
WO (1) WO2015107241A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094658A1 (es) 2014-01-14 2015-08-19 Fast Rehydration Llc Formulación de sales de rehidratación liposomal
US10751283B2 (en) 2014-01-14 2020-08-25 Capability Building, Inc. Liposomal rehydration salt formulation and associated methods of use
WO2023230636A2 (en) * 2022-05-27 2023-11-30 The Coca-Cola Company Fast hydration formulation and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534300B1 (en) * 1999-09-14 2003-03-18 Genzyme Glycobiology Research Institute, Inc. Methods for producing highly phosphorylated lysosomal hydrolases
EP2338478B1 (en) 2002-06-28 2014-07-23 Protiva Biotherapeutics Inc. Method for producing liposomes
US7112273B2 (en) * 2002-09-27 2006-09-26 Nxstage Medical, Inc. Volumetric fluid balance control for extracorporeal blood treatment
US20050008685A1 (en) * 2003-07-07 2005-01-13 Mitchell Cheryl R. Oral rehydration compositions containing liposomes
US20090017167A1 (en) * 2007-07-11 2009-01-15 Herbalife International Inc. Mixture and beverage made therefrom for protecting cellular hydration
NZ594995A (en) * 2009-03-12 2013-06-28 Alnylam Pharmaceuticals Inc LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES
AR094658A1 (es) 2014-01-14 2015-08-19 Fast Rehydration Llc Formulación de sales de rehidratación liposomal

Also Published As

Publication number Publication date
US20180021372A1 (en) 2018-01-25
US20160331778A1 (en) 2016-11-17
MX2016009229A (es) 2017-03-06
BR112016016269A2 (pt) 2017-08-08
US20180028561A1 (en) 2018-02-01
US10238687B2 (en) 2019-03-26
WO2015107241A1 (es) 2015-07-23
US20180049983A1 (en) 2018-02-22
AU2015207485B2 (en) 2018-01-25
AU2015207485A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
CL2015002066A1 (es) Composiciones que incluye agentes para conferir carácter hidrofóbico y estabilizantes y métodos para elaborar y usar los mismos.
AR094643A1 (es) Complejo de haluro de aminoácido y zinc con cisteína
BR112017011215A2 (pt) partículas de distribuição de pró-flavorizante
MA38399A1 (fr) Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique
AR091959A1 (es) Agentes de sosten sinteticos y agentes de sosten monodispersos y metodos para la elaboracion de los mismos
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
CO2017002506A2 (es) Nuevos activadores de la guanilato ciclasa soluble y su uso
CL2014001060A1 (es) Compuestos derivados de aril-quinolina; proceso de obtencion; composicion farmaceutica que los comprende y uso en el tratamiento o profilaxis de la diabetes tipo 2, la aterosclerosis, cancer, entre otras enfermedades.
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
CY1123892T1 (el) Κρυσταλλικες μορφες του 6-((6,7-διμεθοξυκιναζολιν-4-υλο)οξυ)-ν,2-διμεθυλοβενζοφουρανο-3-καρβοξαμιδιου
AR110378A1 (es) Métodos para determinar el estado del cáncer colorrectal en una persona
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
ECSP16058769A (es) Composicion para la administracion oral de agente bioactivos
AR094658A1 (es) Formulación de sales de rehidratación liposomal
AR098024A1 (es) Fármaco para la prevención y/o tratamiento de la poliquistosis renal
CL2016003155A1 (es) Composiciones de cuidado bucal
AR106559A1 (es) Suspensión acuosa para administración oral y método para su preparación
BR112017006918A2 (pt) formulações nanoestruturadas para liberação de silibinina e outros ingredientes ativos para o tratamento de doenças oculares
UY37065A (es) Método de purificación
CL2017000948A1 (es) Textile compuesto que consiste en fibras naturales y/o sintéticas y/o artificiales y partículas lignocelulósicas
BR112018004244A2 (pt) formulações sólidas de pirofosfato férrico solúvel, kits e seus métodos de uso
CO2017002963A2 (es) Espiro-tiazolonas
CR20140526A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
AR101270A1 (es) Composición abrasiva para el cuidado oral
CL2015001590A1 (es) Composicion para el cuidado oral que comprende; (i) un agente blanqueador peroxido y (ii) un abrasivo en la forma de particulas que estan pre-recubiertas por un acido graso c2-c30 saturado, un acido graso c12-c30 mono-saturado, silicona, o sus mezclas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure